Phenotypic characterization of 81-week-old NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Subjects:

NMIIC expression and muscle weight in the soleus of 82-86-week-old mice. by Hiroki Hamaguchi (22783780)

Subjects:

Evaluation of mitochondrial protein expression and morphology in NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Subjects:

Raw data for all figures and supporting information. by Hiroki Hamaguchi (22783780)

Subjects:

Proliferation and differentiation of myoblasts derived from satellite cells in WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Subjects:

Confirmation of NMIIC expression. by Hiroki Hamaguchi (22783780)

Subjects:

Expression of non-muscle myosin (NM) IIC in skeletal muscle cells. by Hiroki Hamaguchi (22783780)

Subjects:

Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

Subjects:

Comparison of soleus muscle weight and fiber size histogram between young and aged WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B) according to age of 65 years,... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with immunodepression in France in 2020 (multivariab... by Benjamin Wyplosz (22032756)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B), who are at risk of pneumococc... by Benjamin Wyplosz (22032756)

Subjects:

Study population: patients living with comorbidities (on the left) and immunosuppressive conditions (on the right) who are at risk of pneumococcal disease in France in the year 202... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with comorbidities in France in 2020 (multivariable... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics of patients at risk of pneumococcal disease in France in 2020 and vaccination rates. by Benjamin Wyplosz (22032756)

Subjects:

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) STZ mice show changes in glomerular morphology. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. by Andrey V. Cybulsky (4007012)

Subjects:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

Subjects:

Primary data. by Andrey V. Cybulsky (4007012)

Subjects: